WIJNGAARD PETER purchased 50.0% of their position (10K shares) of HEPION PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $22.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/18/2021ACC: 0001104659-21-025200
Director
Since Jun 2020
+10K
Net shares
Net buyer
$22.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
10K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+10K
Price / share
$2.20
Trade value
$22K
% of position
50.0%
2/16/2021
20K→30K
Total
Net shares
+10K
Net value
$22K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/16/2021 | P · Purchase | +10K | $2.20 | $22K | 50.0% | 20K | 30K |
| Total | +10K | $22K | ||||||
Derivative Transactions0
No derivative transactions reported